Edito Fabrizio

2.0k total citations
10 papers, 1.2k citations indexed

About

Edito Fabrizio is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Edito Fabrizio has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in Edito Fabrizio's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (4 papers) and Nuclear Receptors and Signaling (4 papers). Edito Fabrizio is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (4 papers) and Nuclear Receptors and Signaling (4 papers). Edito Fabrizio collaborates with scholars based in Italy, United States and United Kingdom. Edito Fabrizio's co-authors include Vincenzo Bonifati, G. Meco, Nicola Vanacore, Thomas Gasser, Benjámin Bereznai, Donald B. Calne, Bertram Müller‐Myhsok, Ralph Oehlmann, Rolf D. Horstmann and P. Vieregge and has published in prestigious journals such as The Lancet, Nature Genetics and Annals of Neurology.

In The Last Decade

Edito Fabrizio

10 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edito Fabrizio Italy	10	1.1k	631	326	225	153	10	1.2k
Jennifer S. Montimurro United States	14	983 0.9×	487 0.8×	442 1.4×	396 1.8×	231 1.5×	16	1.4k
Katja Hofele Switzerland	8	931 0.9×	769 1.2×	189 0.6×	212 0.9×	234 1.5×	9	1.2k
Kari J. Strain United States	10	476 0.4×	375 0.6×	188 0.6×	277 1.2×	115 0.8×	10	883
Kelly M. Hinkle United States	15	759 0.7×	329 0.5×	269 0.8×	323 1.4×	372 2.4×	18	1.1k
Daniele Sandmann-Keil Germany	7	812 0.8×	380 0.6×	202 0.6×	194 0.9×	243 1.6×	8	1.1k
Barbara Jasińska‐Myga Poland	15	540 0.5×	202 0.3×	124 0.4×	138 0.6×	182 1.2×	29	710
Kindiya D. Geghman United States	7	521 0.5×	307 0.5×	143 0.4×	248 1.1×	177 1.2×	8	798
Michael Neystat United States	7	544 0.5×	445 0.7×	92 0.3×	214 1.0×	134 0.9×	8	841
Szu‐Chia Lai Taiwan	16	381 0.4×	177 0.3×	236 0.7×	179 0.8×	90 0.6×	30	643
M Papp Hungary	11	1.3k 1.2×	765 1.2×	605 1.9×	341 1.5×	417 2.7×	27	1.6k

Countries citing papers authored by Edito Fabrizio

Since Specialization

Citations

This map shows the geographic impact of Edito Fabrizio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edito Fabrizio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edito Fabrizio more than expected).

Fields of papers citing papers by Edito Fabrizio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edito Fabrizio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edito Fabrizio. The network helps show where Edito Fabrizio may publish in the future.

Co-authorship network of co-authors of Edito Fabrizio

This figure shows the co-authorship network connecting the top 25 collaborators of Edito Fabrizio. A scholar is included among the top collaborators of Edito Fabrizio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edito Fabrizio. Edito Fabrizio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Meco, G., et al.. (2009). Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study. Journal of Neural Transmission. 116(7). 881–884. 30 indexed citations

2.

Fabrizio, Edito, et al.. (2007). High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians. BMC Neurology. 7(1). 24–24. 15 indexed citations

3.

Fonzo, Alessio Di, Christan F. Rohé, Joaquim J. Ferreira, et al.. (2005). A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. The Lancet. 365(9457). 412–415. 405 indexed citations

4.

Meco, G., et al.. (2003). Mirtazapine in l-Dopa-Induced Dyskinesias. Clinical Neuropharmacology. 26(4). 179–181. 41 indexed citations

5.

Gasparini, Marina, Vincenzo Bonifati, Edito Fabrizio, et al.. (2001). Frontal lobe dysfunction in essential tremor. Journal of Neurology. 248(5). 399–402. 139 indexed citations

6.

Gasser, Thomas, Bertram Müller‐Myhsok, Zbigniew K. Wszołek, et al.. (1998). A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nature Genetics. 18(3). 262–265. 350 indexed citations

7.

Vaughan, Jenny, Alexandra Dürr, Jean‐Pol Tassin, et al.. (1998). The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases. Annals of Neurology. 44(2). 270–273. 67 indexed citations

8.

Bonifati, Vincenzo, et al.. (1994). Buspirone in Levodopa-Induced Dyskinesias. Clinical Neuropharmacology. 17(1). 73–82. 140 indexed citations

9.

Meco, G., Vincenzo Bonifati, Edito Fabrizio, & Nicola Vanacore. (1994). Worsening of parkinsonism with fluvoxamine—two cases. Human Psychopharmacology Clinical and Experimental. 9(6). 439–441. 15 indexed citations

10.

Vanacore, Nicola, et al.. (1992). Mortality Rates for Parkinson's Disease and Parkinsonism in Italy (1969–1987). Neuroepidemiology. 11(2). 65–73. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact